A Pharmacognostical and Phytochemical study of Sookshma Eladi Choornam
Introduction: Sookshma Eladi choornam is one of the Ayurvedic formulations specially mentioned for Kaphaja Hridroga in Hridroga prakarana of Bhaishajya Ratnavali. Dhamani pratichaya (Atherosclerosis) is one of the diseases of Kaphaja nanatmaja vaydhi which is the more important cause for Ischemic Heart Disease. The cause for Atherosclerosis could be Hyperlipidemias. Eladi choornam is a compound preparation which contains powders of Sookshma ela (Elettaria cardamomum Maton.) and Pippali moolam (root of Piper longum L.,). As these drugs are Katu vipaka in nature they can be used in Hyerlipidemia. To know the efficacy of the drugs their quality parameters are highly essential to manufacture in the large scale. Method: The present study deals with the Pharmacognostical and phyto-chemical study of Sookshma eladi choornam including Thin Layer chromatography study (TLC) as per the standard literature. Result: Consistency of Sookshma eladi choornam is fine powder. Colour was brown, odour was aromatic spicy smell, Taste was pungent, touch was smooth powder form, Qualitative study showed that pH is 4.9, total ash value 12 %, loss on drying is 4.5%, Water soluble matter17%, Alcohol soluble matter 8%, Acid insoluble ash 8.5%. Thin Layer chromatography (TLC) revealed one yellow spot. Dissolution time is 4 minutes and Moisture content was 8%. Phytochemicals as Alkaloids, Glycosides, Tannins, Flavonoids and Phenols were found. Conclusion: Pharmacognostical, phyto-chemical and TLC studies inferred that the formulation meets the minimum quality standards. The study may be used as reference standard in the further quality control researches.
Copyright (c) 2020 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.